Overall rank by patents
#49,116
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Narwhal Medical, Inc.
USPTO PatentsView assignee record - 5 granted patents across 1 technology areas, active 2023–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
5
Total patents granted
1
CPC technology areas
13.0
Avg claims per patent
-
5-year filing velocity
The verdict
Narwhal holds 5 US patents across 1 technology areas, rank #49,116 of 50,000 tracked assignees.
- #49,116
- of 50,000 US assignees by volume
- Top 43%
- by Innovation Score (37.5/100)
- 13.0
- avg claims per patent
Portfolio overview
Narwhal Medical, Inc. has been granted 5 US utility patents between 2023 and 2025, placing Narwhal Medical, Inc. at rank #49,116 across all assignees tracked by PlainPatent. This portfolio spans 1 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.0 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Narwhal Medical, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Narwhal sits between Nanoscope Technologies, Llc (5 patents, rank #49,112) and Nationstar Mortgage Llc (5 patents, rank #49,120) - the closest US assignees by grant volume. The composite Innovation Score of 37.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2023 through 2025, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Narwhal Medical, Inc.'s 13.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 1 subclass reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Narwhal Medical, Inc. against peers pursuing similar technology classes.
Who files at Narwhal's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Nanoscope
Nanoscope Technologies, LLC
5 patents
- Nanotech Analysis…
Nanotech Analysis S.R.L.
5 patents
- Nanoton
Nanoton, Inc.
5 patents
- Nanotronics Health
Nanotronics Health, LLC.
5 patents
- Nat Diagnostics
Nat Diagnostics, Inc.
5 patents
- National Institut…
National Institute for Environmental Studies
5 patents
- National Oilwell…
National Oilwell Vareo, L.P.
5 patents
- Nationstar Mortga…
Nationstar Mortgage LLC
5 patents
- Narwhal Medical ◀
Narwhal Medical, Inc.
5 patents
What this shows Narwhal holds 5 patents at rank #49,116, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Narwhal
By rank, the assignees closest to #49,116 in granted patent volume.
- Nanoscope Technologies, Llc #49,112 · 5 patents
- Nanotech Analysis S.r.l. #49,113 · 5 patents
- Nanoton, Inc. #49,114 · 5 patents
- Nanotronics Health, Llc. #49,115 · 5 patents
- Nat Diagnostics, Inc. #49,117 · 5 patents
- National Institute For Environmental Studies #49,118 · 5 patents
- National Oilwell Vareo, L.p. #49,119 · 5 patents
- Nationstar Mortgage Llc #49,120 · 5 patents
Leaders in A61M (Devices FOR Introducing Media INTO)
Other assignees with the most granted patents in Narwhal's primary technology class.
- Becton, Dickinson And Company 1,249 in class
- Sanofi-aventis Deutschland Gmbh 1,159 in class
- Boston Scientific Scimed, Inc. 901 in class
- Koniniklijke Philips N.v. 836 in class
- Fisher & Paykel Healthcare Limited 773 in class
- Covidien Lp 726 in class
- Terumo Kabushiki Kaisha 724 in class
- Resmed Pty Ltd 682 in class
Narwhal's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
38 Top 43% higher than 57% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 1 | 20.0% |
| 2024 | 3 | 60.0% |
| 2025 | 1 | 20.0% |
Which technologies does Narwhal Medical, Inc. patent most?
Top 1 of 1 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Standard
Frequently Asked Questions
How many patents does Narwhal Medical, Inc. hold?
Narwhal Medical, Inc. holds 5 US granted patents filed between 2023 and 2025, spanning 1 technology areas.
What is Narwhal Medical, Inc.'s Innovation Score?
Narwhal Medical, Inc. has an Innovation Score of 37.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Narwhal Medical, Inc. focus on?
Narwhal Medical, Inc.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 5 patents. The company has filed patents in 1 CPC subclasses total.
Is Narwhal Medical, Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Narwhal Medical, Inc..
What does claim depth mean for Narwhal Medical, Inc.'s patents?
Narwhal Medical, Inc.'s patents average 13.0 claims each. This falls within the standard range, providing solid legal coverage.
How is the Narwhal Medical, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Narwhal's 5 grants land it in the top 43% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Narwhal ranks #49,116 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.